Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business
Kumar Gaurav

Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTD

Shares of pharmaceutical company Aurobindo Pharma rose over 3% in trade on Monday, August 31, after the company announced that its subsidiary had launched a product in the US market.

Following the announcement, Aurobindo Pharma’s share price rose 3.5% to hit an intra-day high of Rs 1,703 apiece on the NSE. Although the stock pared some of its gains, it continued to see strong buying interest.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.